Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AMBI to acquire Nutrition 21 for $10 mil. plus stock at closing under tentative agreement.

This article was originally published in The Tan Sheet

Executive Summary

AMBI ACQUISITION OF NUTRITION 21 FOR $10 MIL. PLUS STOCK at closing was announced as an agreement in principle June 13. Tarrytown, N.Y.-based AMBI (formerly Applied Microbiology) said the acquisition of the San Diego-based trace minerals and dietary supplements developer and marketer would help it create a presence in the dietary supplements market and build on the "foundation" initiated by the recent launch of the Cardia Salt Alternative for the dietary management of hypertension.
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087164

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel